Evidence map›Paper›PMID 30429829›Full record

ReviewFrontiers in endocrinology2018

Timing of Exposure and Bisphenol-A: Implications for Diabetes Development.

Eva Tudurí, Laura Marroqui, Reinaldo S Dos Santos, Iván Quesada, Esther Fuentes, Paloma Alonso-Magdalena

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. The Association between Bisphenol A Exposure and Obesity in Children-A Systematic Review with Meta-Analysis.International journal of environmental research and public health · 2019
    Pooled it
  2. Review
  3. Endocrine disruptors, obesity, and metabolic syndrome.Turkish journal of medical sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects.International journal of environmental research and public health · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eva TuduríCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Laura MarroquiCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Reinaldo S Dos SantosCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Iván QuesadaCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Esther FuentesCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Paloma Alonso-MagdalenaCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas and Instituto de Biología Molecular y Celular, Universidad Miguel Hernández de Elche, Alicante, Spain.
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisphenol-A (BPA) is one of the most widespread endocrine disrupting chemicals (EDCs). It is used as the base compound in the production of polycarbonate and other plastics present in many consumer products. It is also used as a building block in epoxy can coating and the thermal paper of cash register receipts. Humans are consistently exposed to BPA and, in consequence, this compound has been detected in the majority of individuals examined. Over the last decade, an enlarging body of evidence has provided a strong support for the role of BPA in the etiology of diabetes and other metabolic disorders. Timing of exposure to EDCs results crucial since it has important implications on the resulting adverse effects. It is now well established that the developing organisms are particularly sensitive to environmental influences. Exposure to EDCs during early life may result in permanent adverse consequences, which increases the risk of developing chronic diseases like diabetes in adult life. In addition to that, developmental abnormalities can be transmitted from one generation to the next, thus affecting future generations. More recently, it has been proposed that gestational environment may also program long-term susceptibility to metabolic disorders in the mother. In the present review, we will comment and discuss the contributing role of BPA in the etiology of diabetes. We will address the metabolic consequences of BPA exposure at different stages of life and comment on the final phenotype observed in different whole-animal models of study.

Indexed as

Bisphenol-Adiabetesmetabolic programmingpancreatic β-celltiming of exposure

Identifiers

PMID30429829
PMCPMC6220716
OpenAlexW2898756515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.